propranolol has been researched along with Splenic Diseases in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Splenic Diseases: Diseases involving the SPLEEN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eight Sudanese patients with hepatosplenic schistosomiasis and seven Sudanese controls were administered a single oral dose of long acting (LA), propranolol 160 mg; blood propranolol levels were measured at regular intervals for 12 h using g." | 7.67 | Propranolol disposition in patients with hepatosplenic schistosomiasis. ( Ali, HM; Arbab, BM; Harron, DW; Homeida, MM, 1987) |
| "Eight Sudanese patients with hepatosplenic schistosomiasis and seven Sudanese controls were administered a single oral dose of long acting (LA), propranolol 160 mg; blood propranolol levels were measured at regular intervals for 12 h using g." | 3.67 | Propranolol disposition in patients with hepatosplenic schistosomiasis. ( Ali, HM; Arbab, BM; Harron, DW; Homeida, MM, 1987) |
| " It was decided that patients whose portal pressure was reduced by 30% with the use of the drug would not undergo surgery and that treatment would consist of the chronic use of propranolol, associated with sclerosis of esophageal varices." | 1.30 | Systemic and hepatic hemodynamics in hepatosplenic Manson's schistosomiasis with and without propranolol. ( Alfieri, F; Baía, CE; Beer, A; Mies, S; Neto, OB; Pereira, LM; Raia, S; Sette, MJ, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bustinduy, AL | 1 |
| Luzinda, K | 1 |
| Mpoya, S | 1 |
| Gothard, P | 1 |
| Stone, N | 1 |
| Wright, S | 1 |
| Stothard, JR | 1 |
| Mies, S | 1 |
| Neto, OB | 1 |
| Beer, A | 1 |
| Baía, CE | 1 |
| Alfieri, F | 1 |
| Pereira, LM | 1 |
| Sette, MJ | 1 |
| Raia, S | 1 |
| Homeida, MM | 1 |
| Ali, HM | 1 |
| Arbab, BM | 1 |
| Harron, DW | 1 |
3 other studies available for propranolol and Splenic Diseases
| Article | Year |
|---|---|
Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?
Topics: Animals; Anthelmintics; Child; Endomyocardial Fibrosis; Feces; Humans; Liver Diseases; Male; Praziqu | 2014 |
Systemic and hepatic hemodynamics in hepatosplenic Manson's schistosomiasis with and without propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Esophageal and Gastric Varices; Hemodynamic | 1997 |
Propranolol disposition in patients with hepatosplenic schistosomiasis.
Topics: Adolescent; Adult; Female; Humans; Liver Diseases, Parasitic; Male; Middle Aged; Propranolol; Schist | 1987 |